Description
Price: $28.99
(as of Aug 16, 2024 04:28:53 UTC – Details)
Ronnie Coleman Signature Series Creatine-XS
Product Overview
The Ronnie Coleman Signature Series Creatine-XS is a research-proven creatine monohydrate supplement that helps delay fatigue, promotes recovery, and supports muscle growth. This pure, micronized creatine monohydrate powder contains no fillers, flavors, or dyes and mixes easily with your favorite beverage.
Features
- Research-proven creatine monohydrate formula
- 100% pure creatine with no fillers, flavors, or dyes
- Unflavored and easy to mix with water, smoothies, or protein shakes
- 400 servings per container
- High-quality ingredients manufactured in the USA with cGMP and NSF certifications
Benefits
Delay Fatigue
Creatine powder supports the production of ATP, the muscles’ primary source of energy, helping to delay fatigue and keep you energized during intense workouts.
Promote Recovery
Consistent use of Ronnie Coleman creatine, in conjunction with proper diet and training, helps create an environment for optimal muscle recovery and growth.
Support Muscle Growth
Creatine is one of the most scientifically researched supplements, known to help muscles perform at their peak ability and grow to their fullest potential.
Specifications
- Item model number: PROMRCSS42
- Date first available: December 24, 2013
- Manufacturer: Ronnie Coleman Signature Series
- ASIN: B00C75L5MS
- Product dimensions: 5 x 5 x 5 inches; 8 ounces
Pros
- Research-proven formula
- 100% pure creatine with no fillers or additives
- Easy to mix and use
- High-quality ingredients
- Supports muscle growth, recovery, and energy
Cons
- No flavor options available
- May not be suitable for those with certain medical conditions or allergies
- Some users may experience stomach upset or diarrhea when first starting supplementation
Disclaimer
This product is not intended to diagnose, treat, cure, or prevent any disease. Consult with a healthcare professional before starting any new supplement regimen.
Reviews
There are no reviews yet.